[
    [
        {
            "time": "",
            "original_text": "北上资金本月抢筹股名单",
            "features": {
                "keywords": [
                    "北上资金",
                    "抢筹",
                    "名单"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "综合"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "北上资金本月抢筹股名单",
                "Correlation": 6,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 3,
                "Market_Scope": 8,
                "Time_Proximity": 9,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "华兰生物(002007.SZ)第三季归母净利润同比减少0.96%至4.52亿元 盈利能力下降",
            "features": {
                "keywords": [
                    "华兰生物",
                    "归母净利润",
                    "同比下降",
                    "盈利能力下降"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "华兰生物(002007.SZ)第三季归母净利润同比减少0.96%至4.52亿元 盈利能力下降",
                "Correlation": 10,
                "Sentiment": 3,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "华兰生物(002007.SZ)：前三季度净利升0.04%至9.64亿元",
            "features": {
                "keywords": [
                    "华兰生物",
                    "净利",
                    "上升",
                    "前三季度"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "华兰生物(002007.SZ)：前三季度净利升0.04%至9.64亿元",
                "Correlation": 10,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "华兰生物：前三季度净利润同比增长0.04%",
            "features": {
                "keywords": [
                    "华兰生物",
                    "净利润",
                    "同比增长",
                    "前三季"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "华兰生物：前三季度净利润同比增长0.04%",
                "Correlation": 10,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 5,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "28股主力资金净流入超亿元",
            "features": {
                "keywords": [
                    "主力资金",
                    "净流入",
                    "超亿元"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "综合"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "28股主力资金净流入超亿元",
                "Correlation": 5,
                "Sentiment": 6,
                "Importance": 6,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 3,
                "Market_Scope": 8,
                "Time_Proximity": 9,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "【国元医药|点评】华兰生物2020三季报点评 ：流感疫苗放量，Q3营收实现高速增长",
            "features": {
                "keywords": [
                    "华兰生物",
                    "流感疫苗",
                    "放量",
                    "Q3营收",
                    "高速增长"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【国元医药|点评】华兰生物2020三季报点评 ：流感疫苗放量，Q3营收实现高速增长",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "original_text": "青岛海尔生物医疗股份有限公司 关于拟通过全资子公司收购重庆 三大伟业制药有限公司股权的补充更正公告",
            "features": {
                "keywords": [
                    "青岛海尔生物",
                    "全资子公司",
                    "收购",
                    "重庆三大伟业制药",
                    "股权"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "青岛海尔生物医疗股份有限公司 关于拟通过全资子公司收购重庆 三大伟业制药有限公司股权的补充更正公告",
                "Correlation": 8,
                "Sentiment": 6,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 7,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        }
    ]
]